Early occurrence of metastatic differentiated thyroid carcinomas in transgenic mice expressing the A2a adenosine receptor gene and the human papillomavirus type 16 E7 oncogene

Oncogene

Volumn 13, Issue 7, 1996, Pages 1471-1482

  Coppée, Frédérique ^a   Gérard, Anne Catherine ^b   Denef, Jean Francois ^b   Ledent, Catherine ^a   Vassart, Gilbert ^a   Dumont, Jacques E ^a   Parmentier, Marc ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cyclic AMP cascade; E7 oncogene; Hyperthyroidism; Metastatic tumors; Thyroid cancer; Transgenic model

Indexed keywords

ADENOSINE A2 RECEPTOR; THYROGLOBULIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; GOITER; HYPERTHYROIDISM; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RECEPTOR GENE; RECOMBINANT GENE; THYROID CARCINOMA; TRANSGENE; TRANSGENIC MOUSE; VIRUS ONCOGENE; WART VIRUS;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS;

EID: 0029832135     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Adams JM and Cory S. (1991). Science, 254, 1161 - 1167.
2. Akamizu T, Ikuyama S, Saji M, Kosugi S, Kozak C, McBride OW and Kohn LD. (1990). Proc. Natl. Acad. Sci. USA, 87, 5677 - 5681.
3. Asano M, Yukita A, Matsumoto T, Kondo S and Suzuki H. (1995). Cancer Res., 55, 5296 - 5301.
4. Bechtner G, Rieder B, Linsenmaier U, Kellermann J, Greil W and Gärtner R. (1993). Acta Endocrinol. Copenh., 129, 458 - 466.
5. Berns A, Breuer M, Verbeek S and Van Lohuizen M. (1989). Int. J. Cancer Suppl., 4, 22 - 25.
6. Bosari S, Lee AKC, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML. (1992). Hum. Pathol., 23, 755 - 761.
7. Bossi P, Viale G, Lee AKC, Alfano RM, Coggi G and Bosari S. (1995). Cancer Res., 55, 5049 - 5053.
8. Breur M. (1991). Radiat. Environ. Biophys., 30, 181 - 183.
9. Christophe D and Vassart G. (1990). Trends Endocrinol. Metab., 1, 351 - 356.
10. Colin IM, Nava E, Toussaint D, Mailer DM, vanDenhove MF, Lüscher TF, Ketelslegers JM, Denef JF and Jameson JL. (1995). Endocrinology, 136, 5283 - 5290.
11. Daa T, Kodama M, Kashima K, Yokoyama S, Nakayama I and Noguchi S. (1993). Acta Pathol. Jpn., 43, 582 - 589.
12. Denef J-F, Haumont S, Cornette C and Beckers C. (1981). Endocrinology, 108, 2352 - 2358.
13. Dumont JE. (1971). Vitam. Harm., 29, 287 - 292.
14. Dumont JE, Lamy F, Roger P and Maenhaut C. (1992). Physiol. Rev., 72, 667 - 697.
15. Duprez L, Parma J, Van Sande J, Allgeier A, Leclere J, Schvartz C, Delisle MJ, Decoulx M, Orgiazzi J, Dumont J et al. (1994). Nat. Genet., 7, 396 - 401.
16. Emoto N, Isozaki O, Arai M, Murakami H, Shizume K, Baird A, Tsushima T and Demura H. (1991). Endocrinology, 128, 58 - 64.
17. Feiberg AP and Vogelstein B. (1983). Anal. Biochem., 132, 6 - 13.
18. Farnham PJ, Slansky JE and Kollmar R. (1993). Biochim. Biophys. Acta, 1155, 125 - 131.
19. Folkman J. (1990). J. Natl. Cancer Inst., 82, 4 - 6.
20. Folkman J. (1995). Nature Med., 1, 27 - 31.
21. Folkman J and Klagsbrun M. (1987). Science, 235, 442 - 446.
22. Folkman J and Shing Y. (1992). J. Biol. Chem., 267, 10931 -10934.
23. Gerard C, Lefort A, Christophe D, Libert F, Van Sande J, Dumont JE and Vassart G. (1989). Mol. Endocrinol., 3, 2110 - 2118.
24. Goldman CK, Kim J, Wong WL, King V, Brock T and Gillespie GY. (1993). Mol. Biol. Cell., 4, 121 - 133.
25. Greil W, Rafferzeder M, Bechtner G and Gärtner R. (1989). Mol. Endocrinol., 3, 858 - 867.
26. Griep AE, Herber R, Jeon S, Lohse JK, Dubielzig RR and Lambert PF. (1993). J. Virol., 67, 1373 - 1384.
27. Guidi AJ, Fisher L, Harris JR and Schmitt SJ. (1994). J. Natl. Cancer Inst., 86, 614 - 619.
28. Hart IR and Saini A. (1992). Lancet, 339, 1453 - 1457.
29. Harvey M, Vogel H, Lee EY-HP, Bradley A and Donehover LA. (1995). Cancer Res., 55, 1146 - 1151.
30. Hedinger C, Williams ED and Sobin LH. (1989). Cancer. 63, 908 - 911.
31. Kim KJ, Li B, Winer J, Armanini M, Gillett N, Philips HS and Ferrara N. (1993). Nature, 362, 841 - 844.
32. Kondo S, Asano M and Suzuki H. (1993). Biochem. Biophys. Res. Commun., 194 (3), 1234 - 1241.
33. Ledent C, Parmentier M and Vassart G. (1990). Proc. Natl. Acad. Sci. USA. 87, 6176-6180.
34. Ledent C, Dumont JE, Vassart G and Parmentier M. (1991). Endocrinology, 129, 1391-1401.
35. Ledent C, Dumont JE, Vassart G and Parmentier M. (1992). EMBO J., 11, 537 - 542.
36. Ledent C, Marcotte A, Dumont JE, Vassart G and Parmentier M. (1995). Oncogene, 10, 1789 - 1797.
37. Liotta LA, Steeg S and Stetler-Stevenson WG. (1991). Cell, 64, 327 - 336.
38. Lyons J, Landis CA, Harsch C, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, et al. (1990). Science, 249, 655 - 659.
39. Maenhaut C, Van Sande J, Libert F, Abramowicz M, Parmentier M, Vanderhaegen JJ, Dumont JE, Vassart G and Schiffman S. (1990). Biochem. Biophys. Res. Commun., 173, 1169 - 1173.
40. Maenhaut C, Brabant G, Vassart G and Dumont JE. (1992). J. Biol. Chem., 267, 3000 - 3007.
41. Nevins JR. (1992). Science, 258, 424 - 429.
42. Nunez J and Pommier J. (1982). Vitam. Horm., 39, 175 - 229.
43. O'Sullivan CO, Barton CM, Staddon SL, Brown CL and Lemoine NR. (1991). Mol. Carcinog., 4, 345 - 349.
44. Pan H and Griep AE. (1994). Genes Dev., 8, 1285 - 1299.
45. Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and Vassart G. (1993). Nature, 365, 649 - 651.
46. Rangaswamy M, Padhy AK, Gopinath PG, Shukla NK, Gupta K and Kapoor MM. (1989). Nucl. Med. Commun., 10, 679-684.
47. Robbins J, Merino MJ, Boice JD Jr, Ron E, Ain KB, Alexander HR, Norton JA and Reynolds J. (1991). Ann. Intern. Med., 115, 133 - 147.
48. Roger PP, Hotimsky A, Moreau C and Dumont JE. (1982). Mol. Cell. Endocrinol., 26, 165 - 176.
49. Roger PP and Dumont JE. (1984). Mol. Cell. Endocrinol., 36, 79 - 93.
50. Sambrook J. (1989). Molecular cloning : a laboratory manual. Fritsch EF and Maniatis T (2nd ed.). CSH Laboratory Press: USA, section 7.
51. Sato K, Yamaziki K, Shizume K, Kanaji Y, Obara T, Oshumi K, Demura H, Yamaguchi S and Shibuya M. (1995). J. Clin. Invest., 96, 1295 - 1302.
52. Scherberg NH, Vassart G, Lecocq R, Dumont JE and Refetoff S. (1981). Endocrinology, 109, 1650 - 1656.
53. Sinn E, Muller W, Pattengale P, Tepler I, Wallace R and Leder P. (1987). Cell, 49, 465 - 475.
54. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C and Monier R. (1991). Oncogene, 6, 677-679.
55. Thomas GA, Williams D and Williams ED. (1989). Am. J. Pathol., 134, 141 - 147.
56. Thomas GA, Williams D and Williams ED. (1991). Br. J. Cancer, 63, 213 - 216.
57. Usiki K, Heldin N-E, Miyazono K, Ishikawa F, Takaku F, Westermark B and Heldin C-H. (1989). Proc. Natl. Acad. Sci. USA, 86, 7427 - 7431.
58. Van Heuverswyn B, Streydio C, Brocas H, Refetoff S, Dumont JE and Vassart G. (1984). Proc. Natl. Acad. Sci. USA, 81, 5941 - 5945.
59. Viglietto G, Maglione D, Rambaldi M, Cerutti J, Romano A, Trapasso F, Fedele M, Ippolito P, Chiapetta G, Botti G, Fusco A and Persico MG. (1995). Oncogene, 11, 1569 - 1579.
60. Wiebel ER, Kistler GS and Scherle WR. (1966). J. Cell. Biol., 30, 23 - 28.
61. Weidner N, Semple JP, Welch WR and Folkman J. (1991). N. Engl. J. Med., 324, 1 - 8.
62. Williams ED. (1979). Clin. Endocrinol. Metab., 8, 193 - 207.
63. Williams ED. (1992). Toxicol. Lett., 64-65 spec No, 375 - 379.
64. Woeber KA. (1991). Med. Clin. North. Am., 75, 169-178.
65. Zacksenhaus E, Bremner R, Jiang Z, Gill RM, Muncaster M, Sopta M, Philips RA and Gallie BL. (1993). Adv. Cancer Res., 61, 115 - 141.